Sinovac Biotech (SVA) Reports Q2 Loss of $0.17

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. AAPL
6. GOOGL
7. ORCL
8. SPY
9. APLD
10. USO

Go back to Sinovac Biotech (SVA) Reports Q2 Loss of $0.17

Sinovac Reports Unaudited Second Quarter 2016 Financial Results

August 23, 2016 6:00 AM EDT

BEIJING, Aug. 23, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter ended June 30, 2016.

Mr. Weidong Yin, Chairman, President and CEO of the Sinovac, commented, "As forecasted on our first quarter earnings call, we experienced a continued decline to our financial results in the second quarter due to the incident involving the improper distribution and sale of vaccines in Shandong province. This impacted nationwide sales of private-pay market vaccines as vaccine companies halted vaccine delivery to wait for the... More